{"id":19818,"date":"2019-03-13T21:46:47","date_gmt":"2019-03-13T21:46:47","guid":{"rendered":"https:\/\/positivelysharing.wordpress.com\/?p=19818"},"modified":"2019-03-13T21:46:47","modified_gmt":"2019-03-13T21:46:47","slug":"why-young-hiv-women-wont-get-powerful-arv-soon","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2019\/03\/13\/why-young-hiv-women-wont-get-powerful-arv-soon\/","title":{"rendered":"Why young HIV+ women won&#8217;t get powerful ARV soon"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><div id=\"d9691a7e-75bd-42e0-b6b9-6280fada22ee\" class=\"article-widget article-widget-image\">\n<div class=\"wrap\">\n<div class=\"image-container\"><a class=\"image\" href=\"https:\/\/lh3.googleusercontent.com\/9HoanO2TKRdMJu7B1um_asKAgClnDBzz2q1jDMg5_zlB5NokYNiSAlVFitVap15sLXHFJTG1Oqnv6VZmW6edy2heYrnS=s1200\"><img decoding=\"async\" src=\"https:\/\/lh3.googleusercontent.com\/9HoanO2TKRdMJu7B1um_asKAgClnDBzz2q1jDMg5_zlB5NokYNiSAlVFitVap15sLXHFJTG1Oqnv6VZmW6edy2heYrnS=s750\" alt=\"ARV drugs\" \/><\/a><\/p>\n<div class=\"image-text\"><span class=\"title\"><strong>WAR on HIV-Aids<\/strong>\u00a0<\/span><span class=\"description\">ARV drugs\u00a0<\/span><br \/>\n<span class=\"author\">Image:\u00a0<span class=\"name\">FILE<\/span><\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<div id=\"2344f9cb-ce55-452c-b49d-be537f9d078b\" class=\"article-widget article-widget-text\">\n<div class=\"wrap\">\n<div class=\"text\">\n<p>&nbsp;<\/p>\n<p>Young HIV-positive women will wait longer to access the powerful DTG antiviral drug.<\/p>\n<p>DTG (Dolutegravir) is the preferred first-line ARV in Kenya, but not recommended for women aged 15-49 because it can deform the spines of unborn babies. <a href=\"https:\/\/www.the-star.co.ke\/news\/2019-03-14-why-young-hiv-women-wont-get-powerful-arv-soon\/\">Read More<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>WAR on HIV-Aids\u00a0ARV drugs\u00a0 Image:\u00a0FILE &nbsp; Young HIV-positive women will wait longer to access the powerful DTG antiviral drug. DTG (Dolutegravir) is&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"post-19818","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-hiv"},"jetpack_featured_media_url":"","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/19818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=19818"}],"version-history":[{"count":0,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/19818\/revisions"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=19818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=19818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=19818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}